Literature DB >> 15212325

Hydrogel probe for iontophoresis drug delivery to the eye.

Esther Eljarrat-Binstock1, Frederik Raiskup, Joseph Frucht-Pery, Abraham J Domb.   

Abstract

The aim of this study was to evaluate the use of a solid hydrogel loaded with a drug solution as a probe for ejecting drugs to the eye upon application of low current iontophoresis. Hydroxyethyl methacrylate (HEMA), cross-linked with ethylene glycol dimethacrylate (EGDMA), and cross-linked arabinogalactan or dextran were prepared to form solid hydrogels. The hydrogels were examined for their mechanical suitability, absorption of drug solution and in vitro release properties when applying an iontophoretic current through the drug-loaded hydrogel into a solid-agar surface. Transconjunctival and transscleral iontophoresis of gentamicin sulfate was studied in healthy rabbits using drug-loaded disposable HEMA hydrogel disc probes. Gentamicin concentrations in different eye segments were assayed using a fluorescence polarization immunoassay. Preliminary corneal toxicity was examined in rabbits using a current intensity of 2.5 and 5.1 mA/cm2 for 60 and 120 s. The most appropriate hydrogel is composed of HEMA, 2% EGDMA and 75% water. lontophoresis onto agar gel was found indicative for the evaluation of iontophoretic activity of a hydrogel. Transscleral iontophoretic treatment resulted in high concentrations of drugs in the posterior segments of the eye. Application of iontophoresis onto the rabbit eye caused a reversible swelling of the cornea which lasted a few hours after application. Low current iontophoresis using drug-loaded hydrogel has a potential clinical value in obtaining high drug concentration at posterior segments of the eye.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15212325     DOI: 10.1163/156856204323005271

Source DB:  PubMed          Journal:  J Biomater Sci Polym Ed        ISSN: 0920-5063            Impact factor:   3.517


  4 in total

Review 1.  New techniques for drug delivery to the posterior eye segment.

Authors:  Esther Eljarrat-Binstock; Jacob Pe'er; Abraham J Domb
Journal:  Pharm Res       Date:  2010-02-13       Impact factor: 4.200

2.  Ocular drug delivery targeted by iontophoresis in the suprachoroidal space using a microneedle.

Authors:  Jae Hwan Jung; Bryce Chiang; Hans E Grossniklaus; Mark R Prausnitz
Journal:  J Control Release       Date:  2018-03-02       Impact factor: 9.776

3.  International patenting in ophthalmology: An analysis of its structure and relevance for the development of drugs and diagnostics.

Authors:  Hermann A M Mucke; Peter Mucke; Eva Mucke
Journal:  Clin Ophthalmol       Date:  2009-06-02

Review 4.  Selected Medicines Used in Iontophoresis.

Authors:  Tomasz M Karpiński
Journal:  Pharmaceutics       Date:  2018-10-25       Impact factor: 6.321

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.